These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12116247)

  • 21. Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.
    Bosco AF; Norton ME; Lieberman E
    Obstet Gynecol; 1999 Dec; 94(6):1020-3. PubMed ID: 10576193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population.
    Monaghan KG; Feldman GL
    Prenat Diagn; 1999 Jul; 19(7):604-9. PubMed ID: 10419606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
    Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
    J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
    Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
    J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-trimester hyperechogenic bowel in a fetus of Turkish origin carrying a rarely seen mutation of cystic fibrosis.
    Kazandi M; Turan V; Selvi Demirtas G; Akercan F; Aykut A; Ozkinay F
    Arch Iran Med; 2012 Jul; 15(7):449-51. PubMed ID: 22724884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.
    Sepulveda W; Leung KY; Robertson ME; Kay E; Mayall ES; Fisk NM
    Obstet Gynecol; 1996 Jan; 87(1):103-6. PubMed ID: 8532242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel.
    Stipoljev F; Sertić J; Kos M; Misković B; Obrad-Sabljak R; Stavljenić-Rukavina A; Latin V; Kurjak A
    J Matern Fetal Med; 1999; 8(2):44-7. PubMed ID: 10090489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple, fast and inexpensive method for mutation scanning of CFTR gene.
    Figueredo Lago JE; Armas Cayarga A; González González YJ; Collazo Mesa T
    BMC Med Genet; 2017 May; 18(1):58. PubMed ID: 28545452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-trimester hyperechogenic bowel in a fetus of Japanese origin: caution in interpreting reported CFTR mutation (L548Q).
    Turner CL; Skinner AC; Castle BM; Wellesley DG
    Prenat Diagn; 2006 Sep; 26(9):875-6. PubMed ID: 16941515
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis.
    Radivojevic D; Djurisic M; Lalic T; Guc-Scekic M; Savic J; Minic P; Antoniadi T; Tzetis M; Kanavakis E
    Genet Test; 2004; 8(3):276-80. PubMed ID: 15727251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study.
    Monaghan KG; Feldman GL; Barbarotto GM; Manji S; Desai TK; Snow K
    Am J Med Genet; 2000 Dec; 95(4):361-5. PubMed ID: 11186891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal echogenic bowel and a dilated loop of bowel associated with cystic fibrosis (CF) mutations delta F508 and 2183AA-->G.
    Rush PW; Vats S; Allitto BA; Qureshi F; Feldman GL
    Prenat Diagn; 1998 Jun; 18(6):638-40. PubMed ID: 9664617
    [No Abstract]   [Full Text] [Related]  

  • 37. CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.
    Thauvin-Robinet C; Munck A; Huet F; de Becdelièvre A; Jimenez C; Lalau G; Gautier E; Rollet J; Flori J; Nové-Josserand R; Soufir JC; Haloun A; Hubert D; Houssin E; Bellis G; Rault G; David A; Janny L; Chiron R; Rives N; Hairion D; Collignon P; Valeri A; Karsenty G; Rossi A; Audrézet MP; Férec C; Leclerc J; Georges Md; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Cheillan D; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Izard V; Steffann J; Viville S; Costa C; Drouineaud V; Fauque P; Binquet C; Bonithon-Kopp C; Morris MA; Faivre L; Goossens M; Roussey M; Girodon E;
    J Med Genet; 2013 Apr; 50(4):220-7. PubMed ID: 23378603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel.
    Berlin BM; Norton ME; Sugarman EA; Tsipis JE; Allitto BA
    Obstet Gynecol; 1999 Jul; 94(1):135-8. PubMed ID: 10389734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France.
    des Georges M; Guittard C; Altiéri JP; Templin C; Sarles J; Sarda P; Claustres M
    J Cyst Fibros; 2004 Dec; 3(4):265-72. PubMed ID: 15698946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.